View full meeting coverage »

Eyetube Meeting Coverage:

2018 Euretina Meeting



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Trials on Steroids for Diabetic Eye Disease

  Channels: Retina | Posted 9/21/2018

Albert J. Augustin, MD, discusses the BEVORDEX trial, which compared bevacizumab (Avastin, Genentech) with the dexamethasone intravitreal implant 0.7 mg (Ozurdex, Allergan). Dr. Augustin also shares the results of studies that evaluated the efficacy of switching from anti-VEGF therapy to either the dexamethasone implant or the fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien, Alimera Science) in cases of recalcitrant disease.

Anti-VEGF • Diabetic macular edema, DME • Steroids

11 / 12 Series: 2018 Euretina Meeting